<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "../../nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">102</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:73abe0ce-d97c-5d7c-bee5-b8e6e6fe6a17</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">ARPHA Preprints</journal-title>
        <abbrev-journal-title xml:lang="en">preprints</abbrev-journal-title>
      </journal-title-group>
      <publisher>
        <publisher-name>Pensoft Publishers</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.3897/arphapreprints.e116672</article-id>
      <article-id pub-id-type="publisher-id">116672</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Grant Proposal</subject>
        </subj-group>
        <subj-group subj-group-type="scientific_subject">
          <subject>Bioinformatics</subject>
          <subject>Image processing</subject>
          <subject>Microbiology &amp; Virology</subject>
          <subject>Structural Bioinformatics</subject>
        </subj-group>
        <subj-group subj-group-type="sdg">
          <subject>Industry</subject>
          <subject> innovation &amp; infrastructure</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Open Imaging Data Sharing in EOSC: COVID-19 as Demonstrator</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Karki</surname>
            <given-names>Reagon</given-names>
          </name>
          <email xlink:type="simple">reagon.karki@itmp.fraunhofer.de</email>
          <uri content-type="orcid">https://orcid.org/0000-0002-1815-0037</uri>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Zaliani</surname>
            <given-names>Andrea</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-1740-8390</uri>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Gribbon</surname>
            <given-names>Philip</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Simon</surname>
            <given-names>Carolina</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0002-0735-4317</uri>
          <xref ref-type="aff" rid="A5">5</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Macias</surname>
            <given-names>Jose Ramon</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0003-2621-6806</uri>
          <xref ref-type="aff" rid="A6">6</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Özdemir</surname>
            <given-names>Bugra</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0001-9823-0581</uri>
          <xref ref-type="aff" rid="A7">7</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Mathur</surname>
            <given-names>Aastha</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0001-9734-9767</uri>
          <xref ref-type="aff" rid="A8">8</xref>
        </contrib>
      </contrib-group>
      <aff id="A9">
        <label>9</label>
        <addr-line content-type="verbatim">, , </addr-line>
      </aff>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern Kai 7, Frankfurt 60590, Germany, Frankfurt, Germany</addr-line>
        <institution>Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Theodor Stern Kai 7, Frankfurt 60590, Germany</institution>
        <addr-line content-type="city">Frankfurt</addr-line>
        <country>Germany</country>
      </aff>
      <aff id="A2">
        <label>2</label>
        <addr-line content-type="verbatim">Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, Hamburg 22525, Germany, Hamburg, Germany</addr-line>
        <institution>Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Schnackenburgallee 114, Hamburg 22525, Germany</institution>
        <addr-line content-type="city">Hamburg</addr-line>
        <country>Germany</country>
      </aff>
      <aff id="A3">
        <label>3</label>
        <addr-line content-type="verbatim">Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP), Hamburg, Germany</addr-line>
        <institution>Fraunhofer Institute for Translational Medicine and Pharmacology (ITMP)</institution>
        <addr-line content-type="city">Hamburg</addr-line>
        <country>Germany</country>
      </aff>
      <aff id="A4">
        <label>4</label>
        <addr-line content-type="verbatim">Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD), Frankfurt, Germany</addr-line>
        <institution>Fraunhofer Cluster of Excellence for Immune-Mediated Diseases (CIMD)</institution>
        <addr-line content-type="city">Frankfurt</addr-line>
        <country>Germany</country>
      </aff>
      <aff id="A5">
        <label>5</label>
        <addr-line content-type="verbatim">National Center for Biotechnology (CSIC), Madrid, Spain</addr-line>
        <institution>National Center for Biotechnology (CSIC)</institution>
        <addr-line content-type="city">Madrid</addr-line>
        <country>Spain</country>
      </aff>
      <aff id="A6">
        <label>6</label>
        <addr-line content-type="verbatim">National Center for Biotechnology (CNB-CSIC), Madrid, Spain</addr-line>
        <institution>National Center for Biotechnology (CNB-CSIC)</institution>
        <addr-line content-type="city">Madrid</addr-line>
        <country>Spain</country>
      </aff>
      <aff id="A7">
        <label>7</label>
        <addr-line content-type="verbatim">Euro-BioImaging, Heidelberg, Germany</addr-line>
        <institution>Euro-BioImaging</institution>
        <addr-line content-type="city">Heidelberg</addr-line>
        <country>Germany</country>
      </aff>
      <aff id="A8">
        <label>8</label>
        <addr-line content-type="verbatim">Euro-BioImaging ERIC, Heidelberg, Germany</addr-line>
        <institution>Euro-BioImaging ERIC</institution>
        <addr-line content-type="city">Heidelberg</addr-line>
        <country>Germany</country>
      </aff>
      <author-notes>
        <fn fn-type="corresp">
          <p>Corresponding author: Reagon Karki (<email xlink:type="simple">reagon.karki@itmp.fraunhofer.de</email>).</p>
        </fn>
        <fn fn-type="edited-by">
          <p>Academic editor: </p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2023</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>05</day>
        <month>12</month>
        <year>2023</year>
      </pub-date>
      <volume>4</volume>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/22E4A692-E52B-589D-969E-3F8A4D0DB943">22E4A692-E52B-589D-969E-3F8A4D0DB943</uri>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>11</month>
          <year>2023</year>
        </date>
        <date date-type="accepted">
          <day>30</day>
          <month>11</month>
          <year>2023</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Reagon Karki, Andrea Zaliani, Philip Gribbon, Carolina Simon, Jose Ramon Macias, Bugra Özdemir, Aastha Mathur</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access preprint distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p class="MsoNormal" style="text-align:justify">
          <span arial="" style="font-family:">This Science Project (SP) brings together three different domains of life sciences with the aim to create reproducible workflows, tools and web-services for data visualization. This SP focuses in building resources for handling data from bioimaging, structural and bio-chemical studies. The Euro-Bioimaging will implement a community standard cloud compatible open image data format and data submission workflow for high-throughput screening data. Whereas, Instruct-ERIC will develop a user-friendly web-service to access to multi-dimensional structural and imaging data. Lastly, EU-OpenScreen/Fraunhofer ITMP will create reproducible workflow for generating Knowledge Graphs that represent phenotype-chemotype of diseases. While these resources are being developed, the collaborators will also simultaneously harmonize the resources right from the beginning to enable FAIR data principles. This SP uses COVID-19 as a demonstrator, however the resources will be generalized for any disease of interest. <o:p/></span>
        </p>
      </abstract>
      <funding-group>
        <award-group>
          <funding-source>
            <named-content content-type="project_title">EOSC Future</named-content>
            <named-content content-type="project_identifier">101017536</named-content>
            <named-content content-type="project_funder_id">501100000780</named-content>
            <named-content content-type="project_funder_name">European Commission</named-content>
            <named-content content-type="project_funder_doi">http://doi.org/10.13039/501100000780</named-content>
          </funding-source>
        </award-group>
      </funding-group>
    </article-meta>
  </front>
</article>
